Vimarsana
Biggest News Aggregation in the World

Page 2 - Imux News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imux Today - Breaking & Trending Today

Immunic (NASDAQ:IMUX) Now Covered by Analysts at StockNews.com - Vimarsana News

Immunic (NASDAQ:IMUX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note issued to investors on Thursday. The firm issued a sell rating on the stock. Separately, Wedbush reaffirmed an outperform rating and set a $5.00 price target on shares of Immunic in a research report on Friday, August 4th. View Our […]

Innovis Asset Management LLC Purchases Shares of 80,773 Immunic, Inc. (NASDAQ:IMUX) - Vimarsana News

Innovis Asset Management LLC Purchases Shares of 80,773 Immunic, Inc. (NASDAQ:IMUX)

Innovis Asset Management LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 80,773 shares of the company’s stock, valued at approximately $120,000. Innovis Asset Management LLC owned 0.18% […]

Immunic (NASDAQ:IMUX) Rating Reiterated by Wedbush - Vimarsana News

Immunic (NASDAQ:IMUX) Rating Reiterated by Wedbush

Wedbush restated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com started coverage on Immunic in a research note on Thursday, May 18th. They issued a sell rating on the stock. […]

Source: wkrb13.com
Immunic (NASDAQ:IMUX) Receives Outperform Rating from Wedbush - Vimarsana News

Immunic (NASDAQ:IMUX) Receives Outperform Rating from Wedbush

Wedbush reaffirmed their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday morning, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com initiated coverage on Immunic in a research report on Thursday, May 18th. They set a sell rating on the […]

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush - Vimarsana News

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […]